T1	Chemical	15 56	Gefitinib in combination with bevacizumab
T2	Disease	159 169	NSCLC with
T3	Limited_variation	181 213	EGFR gene mutations , especially
T4	Limited_variation	230 267	exon 19 deletion mutations , although
R1	treats	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T3
R3	treats	Arg1:T1	Arg2:T4
R4	influences	Arg1:T2	Arg2:T1
R5	isAssociatedWith	Arg1:T2	Arg2:T3
R6	isAssociatedWith	Arg1:T2	Arg2:T4
R7	influences	Arg1:T3	Arg2:T1
R8	treats	Arg1:T3	Arg2:T2
R9	influences	Arg1:T3	Arg2:T4
R10	influences	Arg1:T4	Arg2:T1
R11	treats	Arg1:T4	Arg2:T2
R12	influences	Arg1:T4	Arg2:T3
